Neoplastic Meningitis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Ipilimumab and Nivolumab in Leptomeningeal Metastases From Melanoma
Conditions: Leptomeningeal Carcinomatosis; Melanoma Interventions: Drug: Nivolumab; Drug: Ipilimumab Sponsors: Massachusetts General Hospital; Bristol-Myers Squibb Not yet recruiting - verified September 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2016 Category: Research Source Type: clinical trials

Study of Tesevatinib in Subjects With Non-Small Cell Lung Cancer, EGFR Activating Mutation, Prior Treatment With a Tyrosine Kinase Inhibitor, and Brain Metastases or Leptomeningeal Metastases
Conditions: Non-Small Cell Lung Cancer; Leptomeningeal Metastases; Brain MetastasesIntervention: Drug: TesevatinibSponsor: Kadmon Corporation, LLCRecruiting - verified November 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 20, 2015 Category: Research Source Type: clinical trials

Study of Tesevatinib in Subjects With Non-Small Cell Lung Cancer, EGFR Activating Mutation, Prior Treatment With a Tyrosine Kinase Inhibitor, and Brain Metastases or Leptomeningeal Metastases
Conditions: Non-Small Cell Lung Cancer; Leptomeningeal Metastases; Brain MetastasesIntervention: Drug: TesevatinibSponsor: Kadmon Corporation, LLCRecruiting - verified December 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 20, 2015 Category: Research Source Type: clinical trials